|4Apr 19, 5:08 PM ET

Esser Eric Eugene 4

4 · Telesis Bio Inc. · Filed Apr 19, 2024

Insider Transaction Report

Form 4
Period: 2024-04-17
Esser Eric Eugene
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-04-17+200,000200,000 total
    Exercise: $0.38Exp: 2034-04-17Common Stock (200,000 underlying)
  • Award

    Common Stock

    2024-04-17+100,000129,260 total
Footnotes (2)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 50% of the RSUs shall vest on April 17, 2025, and the remaining 50% of the RSUs shall vest on April 17, 2026.
  • [F2]Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, 25% of the shares subject to the option shall vest on April 17, 2025, and 1/36th of the remaining shares subject to the option shall vest each month thereafter.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4